[9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid | CAS:1133057-98-3

We serve [9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid CAS:1133057-98-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
[9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid

Chemical Name:[9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid
CAS.NO:1133057-98-3
Synonyms:3-BA2NC
Boronic acid, B-[9-(2-naphthalenyl)-9H-carbazol-3-yl]-
B-[9-(2-Naphthalenyl)-9H-carbazol-3-yl]boronic acid
Molecular Formula:C22H16BNO2
Molecular Weight:337.17900
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like [9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,B-[9-(2-Naphthalenyl)-9H-carbazol-3-yl]boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid Use and application,[9-(2-naphthalenyl)-9H-carbazole-3-yl]boronic acid technical grade,usp/ep/jp grade.


Related News: The risk to the UK population has been raised from very low to low, according to Public Health England, which says the country is “well prepared for new diseases”.Ethyl 2-chloropropionate manufacturer Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.2-Bromo-5-fluorobenzotrifluoride supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.4-Methyl-5-thiazolylethyl acetate vendor American Airlines and Delta Air Lines announced more flight cancellations to China on Saturday as coronavirus cases continued to rise.According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.